Diesel : le Sénat dénonce à la justice le pneumologue payé par Total

Loi Bertrand, Sunshine act, loi de réforme du médicament, Market iT

C’est une première dans l’histoire parlementaire. Le bureau du Sénat a décidé, à l’unanimité, jeudi 28 avril, de demander au président du Sénat, Gérard Larcher, de saisir le parquet « sur les suites à donner aux déclarations litigieuses tenues sous serment » par le professeur Michel Aubier, chef du service de pneumologie à l’hôpital Bichat. Le pneumologue est accusé d’avoir menti sous serment devant les sénateurs sur ses liens d’intérêts avec le groupe Total, lors de son audition, le 16 avril 2015, devant la commission d’enquête « sur le coût économique et financier de la pollution de l’air ». Ainsi …

Read More »

#Health: Clinical trials, transparency and getting the message across

Transparency is a buzz word these days. We expect to see it in declarations by our politicians, company financial results, in science, and in decisions made on medicines and treatments by health-care bodies, writes European Alliance for Personalised Medicine Executive Director Denis Horgan. The latter are usually based on clinical trial results regarding safety and efficacy, as well as, inevitably, cost. The European Medicines Agency, or EMA, is quoted as saying just over a year ago: “We…have set new standards for clinical trial data transparency by adopting two landmark policies.” These were a 2010 policy on access to document and a …

Read More »

Maroc | Médecins-labo : Les «cadeaux» interdits !

Seules les conventions à but scientifique ou de recherches seront exemptes de l’application de cette future loi. Mais les parlementaires ont voulu verrouiller le recours aux conventions qui doivent recevoir l’aval du SGG sur un avis de l’Ordre des médecins. Quelle relation entretient l’industrie pharmaceutique avec les professionnels de la santé ? Les députés de la majorité se sont posé la question et leur réponse a été une proposition de loi. Il faut dire que les relations entre médecins et l’industrie pharmaceutique font partie des tabous. Mais la majorité parlementaire compte bien briser ce tabou par le biais de cette …

Read More »

Time for some New Zealand sunshine?

Mandatory disclosure of financial payments was made law in the US in 2010 by the Physician Payment Sunshine Act (PPSA). All payments individual US doctors or their institutions have received are available through OpenPaymentsData. Since the US legislation has been enacted, Australia and European countries have either enacted or begun to enact similar legislation. The situation in New Zealand, however, remains that we do not have a mechanism for disclosure of payments to doctors from industry. Together with colleagues from the University of Auckland, we set out the issues in an editorial in the New Zealand Medical Journal in March …

Read More »

NHS England vs AP-HP : Managing conflicts of interest

Following a string of allegations against potential conflicts of interest in Clinical Commissioning Group contract awards, NHS England has announced a shake-up of its policy within the health service. Incoming changes include new positions for ‘conflicts of interest guardians’, strengthened statutory guidance and a new cross-system task group chaired by NHS England chairman Sir Malcolm Grant. These reforms are the result of months of discussions with senior leaders in CCGs, internal audit colleagues and NHS England’s legal team. The organisation will kick off a four-week consultation during April and will take final guidance to its board in May, with a …

Read More »

Canadian drug companies agree to divulge how much they pay doctors, health groups

Amid ongoing controversy over the fees pharmaceutical companies pay doctors, 10 Canadian-based firms have agreed to divulge how much cash they hand over to physicians and health organizations every year. They say the voluntary program should make the financial ties between pharma and medicine more visible – and help “neutralize” charges of conflict of interest. The firms plan to start publishing statistics on their overall payments to health professionals next year, though will stop short of releasing figures for individual physicians, as now required in the United States. “To us, building trust is fundamental – to actually meet or exceed …

Read More »